Beyond the Knife in Renal Cell Carcinoma: A Systematic Review—To Ablate or Not to Ablate?
Open Access
Abstract
Intensified systemic therapy in metastatic renal cell carcinoma (mRCC) has led to improved patient outcomes. Patients commonly require local control of one or a few metastases. The aim was to evaluate metastasis-directed ablative therapies in extracranial mRCC. Two databases and one registry were searched, using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) approach, for all prospective and matched-pair case–control mRCC studies of radiofrequency ablation (RFA), cryotherapy, microwave ablation (MWA), and stereotactic body radiotherapy (SBRT). Eighteen studies were identified. Fourteen investigated SBRT in 424 patients. Four thermal ablation studies were identified: two cryotherapy (56 patients) and two RFA studies (90 patients). The median participant number was 30 (range 12–69). The combined median follow-up was 17.3 months (range 8–52). Four SBRT studies reported local control (LC) at 12 months, median 84.4% (range 82.5–93). Seven studies (six SBRT and one cryotherapy) reported an LC rate of median 87% (79–100%). Median overall survival (OS) was reported in eight studies (five SBRT, two cryotherapy, and one RFA) with a median of 22.7 months (range 6.7–not reached). Median progression-free survival was reported in seven studies (five SBRT, one cryotherapy, and one RFA); the median was 9.3 months (range 3.0–22.7 months). Grade ≥ 3 toxicity ranged from 1.7% to 10%. SBRT has excellent local control outcomes and acceptable toxicity. Only four eligible thermal ablative studies were identified and could not be compared with SBRT. Translationally rich definitive studies are warranted.Keywords
This publication has 106 references indexed in Scilit:
- Cytoreductive radiofrequency ablation in patients with metastatic renal cell carcinoma ( RCC ) with small primary tumours treated with sunitinib or interferon‐αBJU International, 2013
- Current oncologic applications of radiofrequency ablation therapiesWorld Journal of Gastrointestinal Oncology, 2012
- Prospective evaluation of spinal reirradiation by using stereotactic body radiation therapyCancer, 2011
- Management of Spinal Metastases From Renal Cell Carcinoma Using Stereotactic Body RadiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Risk of Fracture After Single Fraction Image-Guided Intensity-Modulated Radiation Therapy to Spinal MetastasesJournal of Clinical Oncology, 2009
- Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell CarcinomaJournal of Clinical Oncology, 2009
- Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failureJournal of Neurosurgery: Spine, 2007
- Cryoablation of liver tumours – a review of mechanisms, techniques and clinical outcomeMinimally Invasive Therapy & Allied Technologies, 2006
- A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinomaActa Oncologica, 2006
- Stereotactic radiosurgery for spinal metastases from renal cell carcinomaJournal of Neurosurgery: Spine, 2005